Noro-Moseley Partners

What is Noro-Moseley Partners?

Noro-Moseley Partners, based in Atlanta, Georgia, is an early growth equity firm that specializes in investing in early-growth-stage companies across the United States, particularly in the technology and healthcare sectors. Founded in 1983, they have established a reputation for providing not just financial support but also strategic guidance to their portfolio companies. They target businesses experiencing rapid scaling, especially B2B software and healthcare companies, and those led by strong management teams.

Noro-Moseley Partners looks for companies with year-over-year growth of 50% or more, compelling unit economics, and a revenue run rate of $2M to $20M. They aim to disrupt markets and prefer to invest in companies that have received less than $20M in prior funding.

Their investment range is between $5 million and $60 million, aligning with their capability to foster significant growth and market disruption within their investees. Their portfolio and exits reflect a strong track record, showcasing more than $4 billion in aggregate enterprise value since 2015. The team's expertise is exemplified through their successful partnerships, with CEOs expressing trust and valuing the insights and experiences that Noro-Moseley Partners contributes beyond capital investment.

The firm's strategy includes creating boards of operators with significant exit experiences and providing substantial support through various business transitions, including shifts to SaaS models and navigating challenges like the pandemic.